Rockwell Medical Repeats $400 Million to $450 Million Revenue Projection

Rockwell Medical reiterated a projection that its combined business with Vantive’s hemodialysis business could generate $400 million to $450 million in annual revenue, with the acquisition expected to close in mid-2027.

The company repeated the projection in its Nov. 12 third-quarter results release. It depends on business performance, foreign exchange rates, market conditions and successful integration.

Rockwell agreed Nov. 3 to acquire Vantive’s hemodialysis business, including equipment, water treatment systems and technical services. The deal’s previously disclosed terms set a $125 million base price, subject to customary adjustments. The transaction is expected to close in mid-2027, pending regulatory approvals and other closing conditions.

Rockwell also pulled its 2026 outlook for net sales, gross margin, adjusted EBITDA and operating cash flow, pointing to expected transaction and financing costs.